HYCU Delivers Industry-First Backup for Microsoft 365 and Cloud Services With 100% Data Control and Storage Efficiency 21-05-2025, 02:01

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Europe Advanced CO2 Sensor Market Is Predicted To Reach USD 16-03-2023, 14:36